| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/07/2005 | US20050148076 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 07/07/2005 | US20050148074 Umbillical cord extract for use in propagation of bone and adipocyte tissues; tissue engineering; tissue repair; regenerative medicine |
| 07/07/2005 | US20050148073 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050148071 Production of tyrosine hydroxylase positive neurons |
| 07/07/2005 | US20050148070 Propagating human progenitor cell using nutrient broth free of mammalian fetal serum; tissue engineering; regenerative medicine |
| 07/07/2005 | US20050148069 IGF-1 instructs multipotent adult CNS neural stem cells to an oligodendroglial lineage |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148059 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions |
| 07/07/2005 | US20050148058 Protein stabilization |
| 07/07/2005 | US20050148057 Carbonyl reductases, polynucleotides comprising DNA encoding the same, methods for producing the same, and methods for producing optically active alcohol utilizing the same |
| 07/07/2005 | US20050148054 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamics acid |
| 07/07/2005 | US20050148051 Cloning and characterization of a human adenylyl cyclase |
| 07/07/2005 | US20050148032 Chemoselective ligation |
| 07/07/2005 | US20050148028 Matrix membrane fusion protein with improved solubility in membrane-free and detergent-free aqueous environments for use in identifying modulators of membrane transport |
| 07/07/2005 | US20050148020 ATM kinase compositions and methods |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050147969 Genes associated with mast cell activation |
| 07/07/2005 | US20050147960 Propagating multipotent cells on biological scaffold in presence of cell growth factor and determining and/or screening for controlled development, self-assembly or differentiation; regenerative medicine; tissue engineering |
| 07/07/2005 | US20050147959 In vitro system which propagates cells for use in screening drugs, modeling pathological conditions, testing toxicity of chemical agents or for genomic/proteomic analysis |
| 07/07/2005 | US20050147692 Methods, compositions and devices for inducing stasis in tissues and organs |
| 07/07/2005 | US20050147684 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147683 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147682 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147652 Cell delivery system |
| 07/07/2005 | US20050147646 Preparing homogeneous water-based gelatin solution, adding emulsifier with HLB value >9, adding first composition comprising organic solvent and emulsifier with HLB value >9, adding second composition comprising organic solvent and emulsifier with HLB value <8, and solidifying; implants, healing tissues |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147610 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 07/07/2005 | US20050147603 Employing nonimmunogenic blood products from patients with autoimmune disease |
| 07/07/2005 | US20050147597 Isolating autologous mononuclear cells and transplanting locally into injured tissue |
| 07/07/2005 | US20050147596 Preferably, the fibroblasts are obtained from a tissue which is the same type of tissue as that of which the wound is comprised or a tissue in which the fistula exists; also preferably, the fibroblasts are cultured in the animal's own serum. |
| 07/07/2005 | US20050147590 Immunogenic minicells and methods of use |
| 07/07/2005 | US20050145188 Growing marine fish in fresh water |
| 07/07/2005 | DE10350054A1 Recombinant animal cell system expressing a G-protein coupled receptor and a calcium ion channel, useful for identifying receptor activators with potential therapeutic uses |
| 07/07/2005 | CA2648274A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2551503A1 Gene expression technique |
| 07/07/2005 | CA2550489A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2549956A1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 07/07/2005 | CA2549937A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 07/07/2005 | CA2549904A1 Drug testing system with bio-artificial liver |
| 07/07/2005 | CA2549182A1 Methods and composition for soft tissue feature reconstruction |
| 07/07/2005 | CA2546502A1 A method for gene amplification |
| 07/06/2005 | EP1550722A1 Serotype of adenovirus and uses thereof |
| 07/06/2005 | EP1550721A2 Esterases |
| 07/06/2005 | EP1550720A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 07/06/2005 | EP1550716A1 Manufacturing process for three-dimensional tissue structures und structures obtainable thereby |
| 07/06/2005 | EP1550715A1 Method for the regeneration of tissue |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549953A2 Substrates, devices, and methods for cellular assays |
| 07/06/2005 | EP1549951A2 Semaphorin-like proteins and methods of using same |
| 07/06/2005 | EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells |
| 07/06/2005 | EP1549742A1 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 07/06/2005 | EP1549741A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 07/06/2005 | EP1549740A2 Oligodendrocyte production from multipotent neural stem cells |
| 07/06/2005 | EP1549739A2 Biomimetic urothelium |
| 07/06/2005 | EP1549738A2 Keratinocytes expressing exogenous angiogenic growth factors |
| 07/06/2005 | EP1549737A1 Isolation of target cells, capillaries and microorgans |
| 07/06/2005 | EP1549678A2 Hybridomas producing high levels of human sequence antibody |
| 07/06/2005 | EP1549664A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 07/06/2005 | EP1549659A2 Carotenoid ketolase gene |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549277A1 Induction and maintenance of tolerance to composite tissue allografts |
| 07/06/2005 | EP1468079A4 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 07/06/2005 | EP1421097A4 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 07/06/2005 | EP1045902B1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/06/2005 | EP1017837B1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/06/2005 | EP0937461B1 Use of proteins from the mk family as hematopoietic factor |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | EP0776327B1 New multimerizing agents |
| 07/06/2005 | EP0730651B1 Surface loop structural analogues of fibroblast growth factors |
| 07/06/2005 | CN1636229A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
| 07/06/2005 | CN1636138A Magneto-optical bio-discs and systems including related methods |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636065A Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636055A Isolation and expression of a gene for a nitrilase from acidovorax facilis 72W |
| 07/06/2005 | CN1636054A Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 07/06/2005 | CN1636053A Transplantation of haematopoietic cells |
| 07/06/2005 | CN1636052A Methods for producing hyaluronan in a recombinant host cell |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1635895A Coffee plant with reduced alpha-D-galactosidase activity |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1635115A Human corneal limbal stem cell tissue engineering product nourished by fibroblast and preparing process thereof |
| 07/06/2005 | CN1635114A Process for preparing naturally killing T cells |
| 07/06/2005 | CN1635113A Process for preparing hemapoietic stem cells from mesenchymal stem cells |
| 07/06/2005 | CN1635112A Method for constructing suspension cell culture system for breeding broomrape callus |
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1209461C Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 07/06/2005 | CN1209165C Method for cell adhesion and wound healing |
| 07/06/2005 | CA2452131A1 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 07/05/2005 | US6914172 Soybean cultivar 0088401 |
| 07/05/2005 | US6914125 Scramblase 2 |
| 07/05/2005 | US6914124 Tetracycline-regulated transcriptional activator fusion proteins |